Rimantadine
Back to searchMolecule Structure
Scientific Name
Rimantadine
Description of the Drug
Rimantadine is an RNA synthesis inhibitor used to prevent influenza A infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00478
http://www.drugbank.ca/drugs/DB00478
Brand Name(s)
Not Available
Company Owner(s)
Sun Pharmaceutical Industries Inc, Forest Laboratories Inc, Impax Laboratories Inc, Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Influenza virus A matrix protein M2 | SINGLE PROTEIN | INHIBITOR | CHEMBL2052 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2981 | ||
PharmGKB | PA164748038 | ||
Human Metabolome Database | HMDB0014621 | ||
DrugBank | DB00478 | ||
PubChem: Thomson Pharma | 15219656 | ||
PubChem | 5071 | ||
Mcule | MCULE-9027470290 | ||
LINCS | LSM-5143 | ||
BindingDB | 50216627 | ||
EPA CompTox Dashboard | DTXSID2023561 | ||
DrugCentral | 2383 | ||
rxnorm | RIMANTADINE HYDROCHLORIDE | RIMANTADINE | FLUMADINE |
KEGG Ligand | C07236 | ||
ChEBI | 94440 |